Applied DNA Sciences Inc.

NASDAQ: APDN · Real-Time Price · USD
3.86
-0.21 (-5.16%)
At close: Aug 15, 2025, 3:50 PM

Applied DNA Sciences Income Statement

Financials in USD. Fiscal year is October - September.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020
Revenue
983.37K 1.2M 813.11K 797.52K 929.63K 891.16K 779.74K 2.92M 4.41M 5.26M 3.56M 4.3M 6.15M 4.17M 3.04M 1.7M 2.67M 1.62M
Cost of Revenue
612.53K 512.51K 568.21K 552.29K 820.31K 660.07K 700.74K 1.65M 2.6M 2.89M 3.14M 3.26M 3.66M 3.06M 2.95M 550.46K 356.61K 242.56K
Gross Profit
370.85K 684.11K 244.9K 245.23K 109.33K 231.1K 79K 1.27M 1.81M 2.38M 416.76K 1.04M 2.49M 1.11M 89.98K 1.15M 2.31M 1.37M
Operating Income
-3.46M -2.96M -3.27M -3.35M -3.62M -3.79M -4.17M -2.86M -2.7M 1.42M -4.37M -2.84M -1.99M -4.63M -4.46M -3.37M -2.32M -2.97M
Interest Income
60.34K 71.44K 91.33K 36.3K 15.35K 33.32K 41.22K 26.78K 3.64K 3.69K 1.39K n/a 5.54K 273.00 n/a 3.57K 13.84K n/a
Pretax Income
-3.34M -2.67M -3.31M 1.85M -4.49M -1.13M -3.62M -3.11M 551.18K -3.84M -664.55K -1.12M -1.76M -4.72M -4.51M -3.45M -1.52M -4.81M
Net Income
-27.22M -2.64M -3.3M 1.88M -4.47M -1.18M -3.59M -3.1M 588.34K -3.84M -773.07K -1.12M -1.13M -4.72M -4.51M -3.45M -1.52M -4.81M
Selling & General & Admin
2.98M 2.63M 2.68M 2.68M 3M 3.08M 3.31M 3.29M 3.52M 2.63M 3.87M 3.01M 3.41M 4.66M 2.31M 3.24M 3.56M 3.5M
Research & Development
849.36K 1.02M 831.71K 913.03K 726.87K 935.82K 938.91K 836.12K 988.74K 971.3K 912.88K 863.02K 1.07M 1.08M 1.11M 1.03M 874.05K 748.37K
Other Expenses
n/a n/a n/a n/a 4.58K -13.54K -5.75K -3.47K 661.00 8.85K n/a n/a n/a n/a -52.04K -82.8K -54.87K -53.86K
Operating Expenses
3.83M 3.65M 3.52M 3.59M 3.73M 4.02M 4.25M 4.13M 4.51M 3.6M 4.79M 3.88M 4.48M 5.74M 3.73M 4.52M 4.63M 4.35M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 872.08K n/a n/a 5.44K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -1.19M n/a n/a n/a
Cost & Expenses
4.45M 4.16M 4.08M 4.14M 4.55M 4.68M 4.95M 5.78M 7.11M 6.48M 7.93M 7.13M 8.14M 8.8M 6.68M 5.07M 4.99M 4.59M
Income Tax Expense
23.89M n/a n/a n/a n/a n/a -23.39K -14.43K n/a -874 108.51K -1.76M -632.35K n/a 1.7M n/a n/a n/a
Shares Outstanding (Basic)
1.77M 31.52M 17.74M 4.01M 871.32K 13.67M 678.44K 645.43K 645.43K 640.56K 565.82K 485.03K 404.23K 374.31K 374.73K 361.75K 361.75K 272.9K
Shares Outstanding (Diluted)
1.77M 31.52M 17.74M 4.01M 871.32K 13.67M 678.44K 645.43K 645.43K 645.43K 565.82K 485.03K 404.23K 374.31K 374.73K 361.75K 361.75K 272.9K
EPS (Basic)
-15.35 -0.56 -0.19 0.47 -5.13 -1.8 -5.29 -4.8 0.91 -6 -1.37 -2.32 -2.79 -12.61 -12.04 -9.53 -4.19 -17.62
EPS (Diluted)
-15.35 -0.56 -0.19 0.47 -5.13 -1.73 -5.29 -4.8 0.91 -5.95 -1.37 -2.32 -2.79 -12.61 -12.04 -9.53 -4.19 -17.62
EBITDA
-3.46M -2.91M -3.19M -3.21M -3.43M -3.49M -3.84M -2.51M -2.36M -880.06K -3.92M -2.54M -1.83M -4.39M -3.43M -3.19M -2.12M -2.88M
EBIT
n/a -2.96M -3.27M -3.35M -3.62M -3.79M -4.17M -2.86M -2.7M -1.22M -4.37M -2.86M -2.15M -4.71M -3.64M -3.44M -2.32M -2.97M
Depreciation & Amortization
n/a 58.58K 76.98K 134.16K 186.33K 298.95K 329.68K 349.15K 344.5K 338.92K 327.68K 321.19K 320.86K 320.75K 299.87K 247.77K 199.38K 97.41K